Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
2.450
-0.110 (-4.30%)
At close: Aug 13, 2025, 4:00 PM
2.570
+0.120 (4.90%)
Pre-market: Aug 14, 2025, 9:06 AM EDT
Soligenix Employees
As of December 31, 2024, Soligenix had 16 total employees, including 14 full-time and 2 part-time employees. The number of employees increased by 1 or 6.67% compared to the previous year.
Employees
16
Change (1Y)
1
Growth (1Y)
6.67%
Revenue / Employee
$146
Profits / Employee
-$599,251
Market Cap
8.00M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SNGX News
- 6 days ago - NetworkNewsAudio Announces Audio Press Release (APR) on Promising First-Line Therapy for Rare Skin Cancer - GlobeNewsWire
- 14 days ago - Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet's Disease - PRNewsWire
- 5 weeks ago - Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones - PRNewsWire
- 6 weeks ago - Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions - PRNewsWire
- 2 months ago - Soligenix Highlights Dr. Ellen Kim's Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials - GlobeNewsWire
- 3 months ago - Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results - PRNewsWire
- 4 months ago - Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks - PRNewsWire
- 5 months ago - IBN Initiates Coverage of Soligenix Inc. - GlobeNewsWire